Albemarle (NYSE:ALB – Get Free Report) released its quarterly earnings data on Wednesday. The specialty chemicals company reported $0.04 EPS for the quarter, missing the consensus estimate of $0.53 by ($0.49), Briefing.com reports. Albemarle had a net margin of 4.02% and a return on equity of 14.53%. The company had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.34 billion. During the same period in the previous year, the company posted $7.33 EPS. The company’s quarterly revenue was down 39.7% compared to the same quarter last year. Albemarle updated its FY 2024 guidance to EPS.
Albemarle Price Performance
Albemarle stock traded down $0.50 during midday trading on Thursday, reaching $93.17. The company’s stock had a trading volume of 4,712,285 shares, compared to its average volume of 3,054,959. Albemarle has a 52 week low of $90.02 and a 52 week high of $214.99. The company has a current ratio of 2.84, a quick ratio of 1.91 and a debt-to-equity ratio of 0.37. The business has a 50-day moving average price of $102.92 and a 200-day moving average price of $115.79. The stock has a market cap of $10.95 billion, a PE ratio of 33.88, a price-to-earnings-growth ratio of 3.45 and a beta of 1.57.
Albemarle Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, October 1st. Shareholders of record on Friday, September 13th will be given a $0.405 dividend. This represents a $1.62 dividend on an annualized basis and a yield of 1.74%. The ex-dividend date of this dividend is Friday, September 13th. This is a boost from Albemarle’s previous quarterly dividend of $0.40. Albemarle’s payout ratio is currently 58.18%.
Insider Buying and Selling at Albemarle
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on the company. Mizuho cut their price target on Albemarle from $128.00 to $103.00 in a report on Wednesday. HSBC downgraded Albemarle from a “buy” rating to a “hold” rating and set a $95.00 price target for the company. in a report on Wednesday, July 17th. Robert W. Baird cut their price target on Albemarle from $170.00 to $127.00 and set an “outperform” rating for the company in a report on Tuesday, July 9th. Wells Fargo & Company downgraded Albemarle from an “overweight” rating to an “equal weight” rating and cut their price target for the company from $145.00 to $100.00 in a report on Thursday, July 11th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on Albemarle from $125.00 to $140.00 and gave the company a “hold” rating in a report on Tuesday, May 7th. Three research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and eight have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $139.10.
Get Our Latest Stock Analysis on ALB
Albemarle Company Profile
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
Featured Stories
- Five stocks we like better than Albemarle
- 3 Small Caps With Big Return Potential
- First Solar Stock: The Dawn of a New Rally in Share Prices
- Find and Profitably Trade Stocks at 52-Week Lows
- Mastercard Stock’s Q2 Financial Results Outshine Competitors
- Technology Stocks Explained: Here’s What to Know About Tech
- Tobacco Giant’s Shares Fall on EPS Miss, Lackluster Pouch Gains
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.